Discovery and development of selective PPAR gamma modulators as safe and effective antidiabetic agents.
IMPORTANCE OF THE FIELD: PPARgamma full agonists (pioglitazone and rosiglitazone) are the mainstay drugs for the treatment of type 2 diabetes; however, mechanism-based side effects have limited their full therapeutic potential. In recent years, much progr..... Read More